Session Details

U037 Caring Beyond Cure: Palliative Care in Dermatology Practice

Sat, Mar 20, 4:30 PM - 5:30 PM
1 CME Available Focus Session NEW

DESCRIPTION

Dermatology and palliative care are rarely mentioned together despite the fields’ shared focus on symptom management and quality of life. This session will introduce palliative care frameworks for dermatologists. Through cases, we will discuss how to deliver bad news, how to engage in multidisciplinary care and with patients’ caregivers, how to assess patients’ goals of care, how to assess symptomatology, and how to effectively manage pain and pruritus in patients with chronic, severe dermatologic conditions. The goal of this session is to provide dermatologists with tangible skills adapted from palliative care to provide effective, patient-focused care in fast-paced dermatology clinics.

LEARNING OBJECTIVES

1.

Apply palliative care principles to dermatologic patients (frameworks for delivering bad news, assessing goals of care, and shared decision making)

2.

Identify and effectively manage symptoms, such as pruritus and pain, in patients with severe, chronic dermatologic conditions or patients at end of life

DIRECTOR

Connie Zhong, MSc, MD, FAAD

Connie Zhong, MSc, MD, FAAD

University of Wisconsin-Madison

SPEAKERS

Rachel E. Meltzer, MD, MPH, FAAD

Rachel E. Meltzer, MD, MPH, FAAD

Brigham & Women's Hospital, Harvard Medical School

Lauren Orenstein, MD, FAAD

Lauren Orenstein, MD, FAAD

Emory University School of Medicine

DISCLOSURES

Rachel E. Meltzer, MD, MPH, FAAD

Apogee Therapeutics – Consultant (1099 relationship)(Honoraria), Stockholder Public Company(Stock); Galderma – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria); Veradermics – Advisory Board(Honoraria);

Lauren Orenstein, MD, FAAD

HS Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Advisory Board(Fees), Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Advisory Board(Fees); Novartis – Advisory Board(Fees), Investigator(Grants/Research Funding); Phrase Health – Stockholder(Stock); UCB Pharma – Advisory Board(Fees);

Connie Zhong, MSc, MD, FAAD

No financial relationships exist with ineligible companies.